Investment adviser · CRD 337211
ZAKARA CAPITAL, LLC
Exempt reporting adviser (ERA)
Exempt reporting advisers use a shorter Form ADV report. Some adviser-level figures are not reported; fund disclosures appear below when available.
NEW YORK, NY, United States · Form ADV filed Mar 23, 2026
Adviser-level assets, account counts and staffing figures are unavailable in this filing. View the reported fund disclosures below →
Private funds & service providers
1 Private fundThe count excludes feeder funds. Funds in the latest filing appear first, ordered by reported gross assets. Earlier funds retain their last reported values.
ZAKARA BIOTECHNOLOGY MASTER FUND LPHedge Fund · Last reported Mar 23, 2026$110MGross asset value
Feeder funds
- ZAKARA BIOTECHNOLOGY FUND, LP
- ZAKARA BIOTECHNOLOGY FUND LTD.
Provider details
- Annual audit
- Yes
- Prime brokers
- Yes
- Custodians
- No
- Administrator other than the adviser
- Yes
- External marketing
- No
KPMG LLP
PCAOB 185
MORGAN STANLEY & CO. LLC
CRD 8209 · SEC 8-15869
Fund details & source
- Fund ID
- 805-8461166365
- Reported beneficial owners
- 2
- Minimum commitment
- $5M
Form ADV 2063368 · Mar 23, 2026 · Schedule D 7.B.(1)
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
Services & filing details
Most recent filing: Mar 23, 2026. View historical filings
Reported services
Not reported in these imported fields
Compensation
Not reported in these imported fields
Principal office
300 PARK AVENUE, 5TH FLOORNEW YORK, NY, 10022, United States
CRD 337211
Filing source
Form ADV 2063368 · Mar 23, 2026 · Items 1 & 5
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.